John D Bucheit

6PUBLICATIONS
23CO-AUTHORS
General practiceBiomechanicsCardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 08, 2026
Implementation of a Pharmacist-Led Service to Expand SGLT2 Inhibitor Use Beyond Diabetes in the Primary Care Setting.

Stacey Cutrell, Kiara Patino, R Oluwafunmito Babalola

|Jan 19, 2024
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial).

Joshua A Jacobs, Catherine G Derington, Alexander R Zheutlin

|Jul 19, 2023
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.

Ibrahim S Alhomoud, Azita Talasaz, Anurag Mehta

|Jun 29, 2022
A Novel Dual Incretin Agent, Tirzepatide (LY3298176), for the Treatment of Type 2 Diabetes Mellitus and Cardiometabolic Health.

John Bucheit, Jessica Ayers, Lauren Pamulapati

|Jan 04, 2020
Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series.

Estela Lajthia, John D Bucheit, Pramit A Nadpara

|Jul 06, 2019
Implementation of pharmacist-administered pediatric vaccines in the United States: major barriers and potential solutions for the outpatient setting.

Nicole E Omecene, Julie A Patterson, John D Bucheit

Pageof 1

Frequent Collaborators

2 joint publications

Evan M Sisson

2 joint publications

Dave L Dixon

1 joint publications

Joshua A Jacobs

1 joint publications

Catherine G Derington